Wieland S - Search Results

1

Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.

Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP. Wolkin A, et al. Among authors: wieland s. Biol Psychiatry. 1994 Sep 1;36(5):317-25. doi: 10.1016/0006-3223(94)90629-7. Biol Psychiatry. 1994. PMID: 7993958 Clinical Trial.

2

Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.

Duncan E, Wolkin A, Angrist B, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J. Duncan E, et al. Among authors: wieland s. Biol Psychiatry. 1993 Oct 15;34(8):523-8. doi: 10.1016/0006-3223(93)90194-i. Biol Psychiatry. 1993. PMID: 8274579 Free article. Clinical Trial.

3

Amphetamine and negative symptoms of schizophrenia.

Sanfilipo M, Wolkin A, Angrist B, van Kammen DP, Duncan E, Wieland S, Cooper TB, Peselow ED, Rotrosen J. Sanfilipo M, et al. Among authors: wieland s. Psychopharmacology (Berl). 1996 Jan;123(2):211-4. doi: 10.1007/BF02246180. Psychopharmacology (Berl). 1996. PMID: 8741946 Clinical Trial.

4

Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

Wolkin A, Duncan E, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J. Wolkin A, et al. Among authors: wieland s. J Neural Transm Gen Sect. 1994;95(1):49-61. doi: 10.1007/BF01283030. J Neural Transm Gen Sect. 1994. PMID: 7857586

5

Relation of neurological soft signs to psychiatric symptoms in schizophrenia.

Mittal VA, Hasenkamp W, Sanfilipo M, Wieland S, Angrist B, Rotrosen J, Duncan EJ. Mittal VA, et al. Among authors: wieland s. Schizophr Res. 2007 Aug;94(1-3):37-44. doi: 10.1016/j.schres.2007.04.017. Epub 2007 May 31. Schizophr Res. 2007. PMID: 17543502

6

Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls.

Duncan E, Bollini AM, Sanfilipo M, Wieland S, Angrist B, Cooper TB, Rotrosen J. Duncan E, et al. Among authors: wieland s. Schizophr Res. 2006 Jan 31;81(2-3):323-6. doi: 10.1016/j.schres.2005.08.001. Epub 2005 Sep 21. Schizophr Res. 2006. PMID: 16181774 No abstract available.

7

Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test.

Wieland S, Lucki I. Wieland S, et al. Psychopharmacology (Berl). 1990;101(4):497-504. doi: 10.1007/BF02244228. Psychopharmacology (Berl). 1990. PMID: 1975107

8

Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.

Wieland S, Kreider MS, McGonigle P, Lucki I. Wieland S, et al. Brain Res. 1990 Jun 18;520(1-2):291-302. doi: 10.1016/0006-8993(90)91718-v. Brain Res. 1990. PMID: 1698505 Free article.

9

Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents.

Wieland S, Belluzzi JD, Stein L, Lan NC. Wieland S, et al. Psychopharmacology (Berl). 1995 Mar;118(1):65-71. doi: 10.1007/BF02245251. Psychopharmacology (Berl). 1995. PMID: 7597124

10

Altered behavioral responses mediated by serotonin receptors in the genetically dystonic (dt) rat.

Wieland S, Lucki I. Wieland S, et al. Brain Res Bull. 1991 Jan;26(1):11-6. doi: 10.1016/0361-9230(91)90185-m. Brain Res Bull. 1991. PMID: 2015508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters